» Authors » Anne Marie Winstone

Anne Marie Winstone

Explore the profile of Anne Marie Winstone including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 240
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Burleigh C, Lynn R, Verity C, Winstone A, White S, Johnson K
Arch Dis Child . 2023 Jul; 108(10):852-856. PMID: 37451833
Objective: To determine the incidence of fetal alcohol syndrome (FAS) in the UK in children aged 0-16 years. Design: Active surveillance was undertaken through the British Paediatric Surveillance Unit between...
2.
Campbell H, Lopez Bernal J, Bukasa A, Andrews N, Baker E, Maunder P, et al.
Pediatr Infect Dis J . 2022 Nov; 42(1):82-84. PMID: 36410008
New pediatric and adult subacute sclerosing panencephalitis cases between 1996 and 2020 were reported based on an established UK registry with no evidence of under-ascertainment using a separate pediatric surveillance...
3.
Verity C, Baker E, Maunder P, Pal S, Winstone A
Dev Med Child Neurol . 2020 Sep; 63(3):287-294. PMID: 32970345
Aim: To report the differential diagnosis in children with progressive intellectual and neurological deterioration (PIND) in the UK. Method: Since 1997 the PIND Study has searched for variant Creutzfeldt-Jakob disease...
4.
Verity C, Winstone A, Will R, Powell A, Baxter P, de Sousa C, et al.
Arch Dis Child . 2018 Oct; 104(4):360-365. PMID: 30337492
Objectives: To report investigations performed in children with progressive neurodegenerative diseases reported to this UK study. Design: Since 1997 paediatric surveillance for variant Creutzfeldt-Jakob disease (vCJD) has been performed by...
5.
Winstone A, Stellitano L, Verity C
Dev Med Child Neurol . 2017 Jun; 59(9):965-972. PMID: 28574146
Aim: To describe the cases of Niemann-Pick type C (NP-C) disease in a United Kingdom epidemiological study of progressive intellectual and neurological deterioration in childhood. Method: Paediatricians notified cases via...
6.
Stellitano L, Winstone A, van der Knaap M, Verity C
Dev Med Child Neurol . 2016 Feb; 58(7):680-9. PMID: 26866636
Aim: To report on the epidemiology of the brain white matter disorders of children identified via a national prospective study. Method: Since 1997 a study of UK children with progressive...
7.
Winstone A, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, et al.
Dev Med Child Neurol . 2014 Jul; 56(11):1117-23. PMID: 25041214
Aim: The aim of this study was to investigate whether children in England with narcolepsy who received the ASO3 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix) differed clinically from unvaccinated...
8.
Miller E, Andrews N, Stellitano L, Stowe J, Winstone A, Shneerson J, et al.
BMJ . 2013 Feb; 346:f794. PMID: 23444425
Objective: To evaluate the risk of narcolepsy in children and adolescents in England targeted for vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine (Pandemrix) from October 2009. Design: Retrospective analysis....
9.
Smith N, Winstone A, Stellitano L, Cox T, Verity C
Dev Med Child Neurol . 2011 Nov; 54(2):176-82. PMID: 22115551
Aim: To report the demographic, phenotypic, and time-to-diagnosis characteristics of children with GM2 gangliosidosis referred to the UK study of Progressive Intellectual and Neurological Deterioration. Method: Case notification is made...
10.
Verity C, Stellitano L, Winstone A, Andrews N, Stowe J, Miller E
Lancet . 2011 Nov; 378(9802):1545-6. PMID: 22035553
No abstract available.